Cocaine use disorder continues be a significant public health concern with no available FDA-approved pharmacotherapies despite decades of research focused on treatment and the neurobiological mechanisms underlying drug addiction. Thus, there remains a critical need for conceptually innovative approaches toward identifying new medications to treat this disease. Current preclinical literature show that analogs of the neuroendocrine hormone glucagon-like peptide-1 (GLP-1) have promising clinical potential, as GLP-1 receptor (GLP-1R) activation reduces the rewarding and reinforcing effects of cocaine in animal models of drug addiction. To expand our knowledge of the neural circuitry and neurobiological mechanisms that underly the effects of GLP...
Glucagon-like peptide 1 (GLP-1) is an incretine hormone that controls consummatory behavior and gluc...
AbstractThe prefrontal cortex mediates many aspects of addiction. In this issue of Neuron, Bowers et...
Understanding the psychobiological basis of relapse remains a challenge in developing therapies for ...
Cocaine use disorder continues be a significant public health concern with no available FDA-approved...
Cocaine use disorder continues be a significant public health concern with no available FDA-approved...
Abnormal glutamate signaling in the brain, particularly in the nucleus accumbens core, contributes t...
Cocaine abuse poses a significant public health concern both in the United States and across the glo...
© 2015 American College of Neuropsychopharmacology. Glucagon-like peptide 1 (GLP-1) and its receptor...
Cocaine abuse and relapse remain a major public health concern in the United States and worldwide fo...
Neurobiological adaptations in the nucleus accumbens (NAc) following withdrawal from drug use are as...
Exendin-4 (Ex4), a long-lasting glucagon-like peptide-1 analog, was reported to exert favourable act...
Relapse to cocaine seeking is associated with potentiated excitatory synapses in nucleus accumbens. ...
Cocaine abuse poses a significant public health concern both in the United States and across the glo...
The functional integrity of the nucleus accumbens (NAC) core and shell is necessary for contextual c...
Accumulating studies suggest that the glucagon-like peptide-1 receptor agonist exendin-4 (Ex4) and t...
Glucagon-like peptide 1 (GLP-1) is an incretine hormone that controls consummatory behavior and gluc...
AbstractThe prefrontal cortex mediates many aspects of addiction. In this issue of Neuron, Bowers et...
Understanding the psychobiological basis of relapse remains a challenge in developing therapies for ...
Cocaine use disorder continues be a significant public health concern with no available FDA-approved...
Cocaine use disorder continues be a significant public health concern with no available FDA-approved...
Abnormal glutamate signaling in the brain, particularly in the nucleus accumbens core, contributes t...
Cocaine abuse poses a significant public health concern both in the United States and across the glo...
© 2015 American College of Neuropsychopharmacology. Glucagon-like peptide 1 (GLP-1) and its receptor...
Cocaine abuse and relapse remain a major public health concern in the United States and worldwide fo...
Neurobiological adaptations in the nucleus accumbens (NAc) following withdrawal from drug use are as...
Exendin-4 (Ex4), a long-lasting glucagon-like peptide-1 analog, was reported to exert favourable act...
Relapse to cocaine seeking is associated with potentiated excitatory synapses in nucleus accumbens. ...
Cocaine abuse poses a significant public health concern both in the United States and across the glo...
The functional integrity of the nucleus accumbens (NAC) core and shell is necessary for contextual c...
Accumulating studies suggest that the glucagon-like peptide-1 receptor agonist exendin-4 (Ex4) and t...
Glucagon-like peptide 1 (GLP-1) is an incretine hormone that controls consummatory behavior and gluc...
AbstractThe prefrontal cortex mediates many aspects of addiction. In this issue of Neuron, Bowers et...
Understanding the psychobiological basis of relapse remains a challenge in developing therapies for ...